Cullinan Therapeutics Inc.
CGEM | NASDAQ
$21.35
+$0.27 (+1.28%)
At close: Sep 21, 2026, 4:00 PM ET
$21.38
+$0.03 (+0.14%)
Pre-market:
Sep 22, 2026, 8:16 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.94M | 18.94M | 18.94M | 18.94M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 77K | 153K | 230K | 230K | 153K | 77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -77K | -153K | -230K | -230K | -153K | -77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.94M | 18.94M | 18.94M | 18.94M |
Operating Income | -221.81M | -240.35M | -241.65M | -241.44M | -234.7M | -208.93M | -196.92M | -187.36M | -183.74M | -171.32M | -191.09M | -178.21M | -162.74M | 114.55M | 144.65M | 142.91M | 154.3M | -101.98M | -67.95M | -62.78M | -55.9M | -53.42M |
Interest Income | 17.45M | 19.73M | 22.21M | 25.11M | 28.4M | 30.55M | 29.66M | 28.07M | 25.56M | 22.81M | 21.63M | 19.07M | 15.55M | 10.92M | 6.61M | 3.38M | 1.15M | 625K | 477K | 419K | 486K | 559K |
Pretax Income | -204.69M | -221.04M | -219.88M | -216.7M | -206.65M | -178.62M | -167.46M | -159.61M | -158.24M | -148.42M | -169.22M | -158.48M | -146.71M | 125.64M | 151.32M | 146.06M | 155.21M | -101.36M | -67.49M | -62.39M | -55.44M | -52.88M |
Net Income | -204.69M | -221.04M | -219.88M | -216.81M | -206.76M | -178.74M | -167.38M | -143.54M | -142.16M | -132.35M | -153.16M | -156.14M | -141.76M | 65.35M | 111.21M | 105.48M | 112.94M | -77.6M | -65.57M | -61.4M | -53.91M | -46.9M |
Selling & General & Admin | 50.33M | 52.28M | 54.25M | 56.49M | 56.21M | 55.13M | 53.86M | 49.87M | 47.5M | 44.02M | 42.42M | 43.14M | 42.25M | 42.73M | 40.19M | 42.37M | 37.98M | 32.11M | 29.15M | 28.22M | 24.11M | 20.91M |
Research & Development | 171.47M | 188.07M | 187.4M | 184.95M | 178.49M | 153.72M | 142.9M | 137.26M | 135.57M | 126.71M | 148.16M | 134.63M | 120.49M | 119.51M | 91.95M | 91.51M | 84.51M | 69.87M | 57.75M | 53.5M | 50.74M | 51.45M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 440K | 440K | 440K | 440K | n/a | -276.79M | -276.79M | -276.79M | -276.79M | n/a | -2K | -2K | -2K | -2K |
Operating Expenses | 221.81M | 240.35M | 241.65M | 241.44M | 234.7M | 208.85M | 196.77M | 187.13M | 183.51M | 171.17M | 191.01M | 178.21M | 162.74M | -114.55M | -144.65M | -142.91M | -154.3M | 101.98M | 86.9M | 81.72M | 74.85M | 72.37M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -77K | -153K | -230K | -230K | -153K | -77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 221.81M | 240.35M | 241.65M | 241.44M | 234.7M | 208.93M | 196.92M | 187.36M | 183.74M | 171.32M | 191.09M | 178.21M | 162.74M | -114.55M | -144.65M | -142.91M | -154.3M | 101.98M | 86.9M | 81.72M | 74.85M | 72.37M |
Income Tax Expense | n/a | n/a | n/a | 117K | 117K | 117K | 117K | -14.12M | -14.12M | -14.12M | -14.12M | -1.86M | -4.38M | 61.69M | 42.12M | 43.98M | 46.5M | -19.57M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.49M | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 44.87M | 44.43M | 43.52M | 43.44M | 43.3M | 41.98M |
Shares Outstanding (Diluted) | 61.49M | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 46.38M | 44.43M | 43.64M | 43.44M | 43.3M | 41.98M |
EPS (Basic) | -3.37 | -3.75 | -3.73 | -3.68 | -3.52 | -3.09 | -3.13 | -2.88 | -3.10 | -3.15 | -3.71 | -3.74 | -3.36 | 1.35 | 2.50 | 2.35 | 2.49 | -1.77 | -1.50 | -1.44 | -1.30 | -1.39 |
EPS (Diluted) | -3.37 | -3.75 | -3.73 | -3.68 | -3.52 | -3.09 | -3.13 | -2.88 | -3.10 | -3.15 | -3.71 | -3.74 | -3.36 | 1.22 | 2.37 | 2.22 | 2.36 | -1.77 | -1.50 | -1.44 | -1.30 | -1.39 |
EBITDA | -208.41M | -224.76M | -219.57M | -216.39M | -206.34M | -178.31M | -167.15M | -159.31M | -163.55M | -153.73M | -174.53M | -163.81M | -146.49M | -151.45M | -125.83M | -131.14M | -121.98M | -101.31M | -67.48M | -62.44M | -55.68M | -53.36M |
EBIT | -208.72M | -225.08M | -219.88M | -216.7M | -206.65M | -178.62M | -167.46M | -159.61M | -163.86M | -154.04M | -174.84M | -164.1M | -146.71M | -151.61M | -125.93M | -131.19M | -122.03M | -101.36M | -67.53M | -62.5M | -55.74M | -53.42M |
Depreciation & Amortization | 316K | 314K | 311K | 309K | 306K | 306K | 306K | 306K | 310K | 314K | 310K | 292K | 221K | 152K | 93K | 46K | 50K | 51K | 53K | 56K | 58K | 61K |
Add to Watchlist
Select watchlists to add or remove CGEM